CStone presents updated results of a registrational study of sugemalimab in patients with stage III NSCLC via oral presentation at WCLC 2022 ...Middle East

GEMSTONE-301 study result was presented at IASLC 2022 World Conference on Lung Cancer. In addition, the leading Principal Investigator Professor Yi-Long Wu was invited to highlight key data in a press conference In the final progression-free survival analysis, sugemalimab showed sustained...

Hence then, the article about cstone presents updated results of a registrational study of sugemalimab in patients with stage iii nsclc via oral presentation at wclc 2022 was published today ( Monday 08/08/2022 - 03:20 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CStone presents updated results of a registrational study of sugemalimab in patients with stage III NSCLC via oral presentation at WCLC 2022 )

Also on site :

• Crash, shooting near Sacramento-area gym leaves 2 injured; Suspect sought
• Grey's Anatomy Brings Back Meredith And Nick For A Tense Reunion — And A Big Question About Their Future
• Trump says US still ‘watching Iran‘ as ‘massive’ fleet heads to Gulf region